🎁 Black Friday: up to 50% off of annual plans
Guardant Health, Inc. (GH)
NASDAQ: GH · Real-Time Price · USD
145.83
+0.24 (0.16%)
At close: Nov 20, 2026, 4:00 PM EST
147.88
+2.05 (1.41%)
After-hours: Nov 20, 2026, 7:50 PM EST

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15
United States Revenue
1.21B923.28M697.16M
International Revenue
67.31M58.74M41.85M
Revenue (Total)
1.28B982.02M739.02M

Revenue Breakdown

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15
Oncology Revenue
845.27M683.60M542.83M
Biopharma and Data Revenue
226.90M210.13M177.58M
Screening Revenue
197.20M79.73M5.12M
Licensing and Other Revenue
9.51M8.56M13.49M
Revenue (Total)
1.28B982.02M739.02M

Revenue Breakdown 2

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15
Precision Oncology Testing Revenue
--687.94M
Development Services and Other Revenue
--51.08M
Revenue (Total)
1.28B982.02M739.02M

Gross Profit

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15
Precision Oncology Testing Gross Profit
--427.36M
Development Services and Other Gross Profit
--21.86M
Gross Profit (Total)
833.70M633.01M449.22M

Key Performance Indicators

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15
Clinical Test Sales Volume
386.00K276.00K206.70K
Biopharmaceutical Test Sales Volume
--40.50K